BioCentury
ARTICLE | Clinical News

Belviq lorcaserin regulatory update

February 23, 2015 8:00 AM UTC

Arena said South Korea approved Belviq lorcaserin as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adult patients with a BMI >=30 kg/m 2 or >=27 kg/m 2 ...